Evaluating postoperative outcomes in patients with liver, bile duct, and pancreatic cancer using the inBody test
Postoperative Outcomes in Patients With Hepato-biliary-pancreatic Cancer According to inBody Test
This study is testing if using the inBody test to measure body composition can help doctors understand how well patients recover after surgery for liver, bile duct, and pancreatic cancer.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years to 90 Years |
| Sex | All |
| Sponsor | Kochi University Academic / other |
| Locations | 1 site (Kochi) |
| Trial ID | NCT05257434 on ClinicalTrials.gov |
What this trial studies
This observational study assesses postoperative outcomes in patients who have undergone surgery for hepato-biliary-pancreatic cancer by utilizing the inBody test, which measures body composition. The study aims to identify correlations between body composition metrics and recovery outcomes post-surgery. By analyzing data from surgically treated patients, the research seeks to provide insights into how body composition may influence recovery and overall health after surgery.
Who should consider this trial
Good fit: Ideal candidates for this study are patients who have undergone surgical treatment for hepato-biliary-pancreatic cancer.
Not a fit: Patients who have experienced significant weight loss prior to surgery, have distant metastases, or have severely impaired organ function may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could help tailor postoperative care and improve recovery strategies for patients with hepato-biliary-pancreatic cancer.
How similar studies have performed: While the use of body composition analysis in postoperative outcomes is gaining interest, this specific approach using the inBody test in this cancer population is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * surgically treated patients Exclusion Criteria: * a body weight loss of \>10% during the 6 months before surgery; the presence of distant metastases; or seriously impaired function of vital organs because of respiratory, renal, or heart disease
Where this trial is running
Kochi
- Takehiro Okabayashi — Kochi, Japan (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.